Researchers have found an effective target in the brain for electrical stimulation to improve mood in people suffering from depression.
As reported in the journal Current Biology on November 29, stimulation of a brain region called the lateral orbitofrontal cortex (OFC) reliably produced acute improvement in mood in patients who suffered from depression at the start of the study.
Those effects were not seen in patients without mood symptoms, suggesting that the brain stimulation works to normalize activity in mood-related neural circuitry, the researchers say.
“Stimulation induced a pattern of activity in brain regions connected to OFC that was similar to patterns seen when patients naturally experienced positive mood states,” says Vikram Rao, of the University of California, San Francisco. “Our findings suggest that OFC is a promising new stimulation target for treatment of mood disorders.”
The team led by Rao and Kristin Sellers in the lab of Edward Chang studied 25 patients with epilepsy who had electrodes placed in the brain for medical reasons to pinpoint the origin of their seizures. Many of those patients also suffered from depression, which is often seen in people with epilepsy. With the patients’ consent, Chang’s team took advantage of those electrodes to deliver small electrical pulses to areas of the brain thought to be involved in regulating mood.
Previous studies have explored deep brain stimulation (DBS) for mood disorders, but its success depends critically on target selection. Targets in other mood-related areas deep in the brain hadn’t always led to reliable improvements.
In the new study, the researchers focused their attention and the electrical stimulation on the OFC. The OFC is a key hub for mood-related circuitry. But it’s also widely regarded as one of the least well-understood brain regions.
“Although OFC is a more superficial target, it shares rich interconnections with several brain regions implicated in emotion processing,” Sellers says. That made this relatively small brain area an attractive target for therapeutic stimulation.
The researchers used the implanted electrodes to stimulate OFC and other brain regions while collecting verbal mood reports and questionnaire scores. Those studies found that unilateral stimulation of the lateral OFC produced acute, dose-dependent mood-state improvement in subjects with moderate-to-severe baseline depression. The changes in brain activity the researchers observed after stimulation closely resembled those seen when people are in a good mood.
The findings show that mood can be immediately improved by electrical stimulation of a relatively small area of brain, the researchers say. They also add to evidence that mood disorders are the result of dysfunction in brain circuits.
The researchers say that plenty of work remains before DBS could enter routine clinical practice. Chang’s team is currently exploring whether stimulation of OFC produces durable improvement in mood over longer periods of time. They also hope to develop a medical device for patients with treatment-resistant mood disorders that can monitor brain activity in OFC and stimulate only when needed to keep that activity within a healthy range.
“Ultimately, it would be ideal if activity in mood-related brain circuits could be normalized indefinitely without patients needing to do anything,” Rao says.
The Latest on: Depression
via Google News
The Latest on: Depression
- Depression genes linked to other diseaseson September 6, 2019 at 10:30 pm
A new research has shown that having depression can make you prone to a number of other unrelated diseases. Chances are, your depression genes can in fact be responsible for putting you at risk of ...
- Five myths about the Great Depressionon September 6, 2019 at 10:18 am
Ninety years ago this fall, the stock market experienced the Great Crash. Shortly thereafter, America’s economy slumped into the Great Depression. Though misconceptions about them abound, these events ...
- New GABA Modulator Promising in Depressionon September 6, 2019 at 8:48 am
SAGE-217, a novel modulator of γ-aminobutyric acid–A (GABA A), reduced depressive symptoms in patients with major depression in a new study. Investigator compared patients who had major depression and ...
- Depression, Burnout, Suicide Among Oncologistson September 6, 2019 at 8:37 am
At the recent 2019 ASCO annual meeting in Chicago, Daniel McFarland, DO, of Memorial Sloan Kettering Cancer Center, discusses some simple maneuvers that can give the physician more free time to ...
- New research suggests gut bacteria may be linked to high blood pressure and depressionon September 6, 2019 at 5:03 am
A study of bacteria in the gut identified differences between people with high blood pressure compared to those with high blood pressure plus depression, according to preliminary research ...
- FA Cup: Buxton striker Martin Pilkington on gambling addiction and depressionon September 5, 2019 at 10:33 pm
Date: 6-8 September Coverage: Thatcham Town v Salisbury live on the Red Button and on the BBC Sport website from 12:30 BST on 7 September When Martin Pilkington scored the winning goal in an FA Cup ...
- The Stigma of Depression Affects Even Doctorson September 5, 2019 at 9:42 am
About four years ago, during my first interview for residency, right out of medical school, a seasoned physician with piercing blue eyes and a gray beard said to me, “I’ve read your application. Now ...
- Hearing aids lower dementia, depression risk for older adultson September 5, 2019 at 8:40 am
Sept. 5 (UPI) --After getting their first hearing aid, older adults have a lower likelihood of anxiety, depression and dementia compared to those who don't, a new study says. However, only about 12 ...
- A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomicson September 5, 2019 at 6:25 am
Individual-level data analyses were based on 2047 unrelated participants (67.2% females) of European ancestry from the NESDA. Detailed descriptions of the rationale, design, and methods for the study ...
via Bing News